Mira Pharmaceuticals Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Mira Pharmaceuticals Inc's ROI in the second quarter of 2026?
Mira Pharmaceuticals Inc recorded a cumulative net loss of $-9 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -106.71%.

Within the Healthcare sector 339 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3422 to 4111.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	365.24 %	200.87 %	77.63 %	-12.84 %	-57.33 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	8	9	10	8	1
Return On Investment (TTM)	-106.71 %	-140.43 %	-210.91 %	-236.25 %	-406.68 %
MIRA's Overall Ranking	# 4111	# 3422	# 3695	# 3636	# 3917
Seq. Investment Change TTM	27.17 %	41.08 %	70.54 %	52.05 %	-17.76 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-9	-10	-10	-7	-8

MIRA Company Profile >> Back to MIRA Roi Comparisons >> See Annual MIRA Return On Investment

Return On Investment MIRA's Ranking
Within:	No.
Industry	# 147
Sector	# 340
Overall	# 4111

Return On Investment Statistics
High	Average	Low
-17.98 %	-186.88 %	-406.68 %
(Sep 30 2024)		(Jun 30 2025)

Financial Statements
Mira Pharmaceuticals Inc's II. Quarter Investments	$ 8 Millions	MIRA's Balance sheet
Mira Pharmaceuticals Inc's II. Quarter Income	$ -1 Millions	Quarterly MIRA's Income Statement
MIRA's Income by Division		See MIRA's Income by Division

MIRA Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023
Total Investments in Millions	10	2	4	0	0
Y / Y Investment Growth	372.4 %	-49.71 %	-	-	-
Net Income in Millions	-10	-8	-12	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-100.49 %	-356.98 %	-273.92 %	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MIRA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MIRA's Competitors
Subscribers only: Roi for Mira Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for MIRA's Customers

Other Ratios
MIRA's Roa	MIRA's Inventory Turnover Ratio	MIRA's Growth Rates	MIRA's Dividend Statistics
	MIRA's Profitability Ratios	MIRA's Asset Turnover Ratio	MIRA's Dividend Growth
MIRA's Roe	MIRA's Valuation Ratios	MIRA's Financial Strength Ratios	MIRA's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-03T16:20:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.